首页> 外文期刊>Biochemical Pharmacology >Mechanism of acridine-based telomerase inhibition and telomere shortening.
【24h】

Mechanism of acridine-based telomerase inhibition and telomere shortening.

机译:基于a啶的端粒酶抑制和端粒缩短的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

The trisubstituted acridine compound BRACO-19 has been developed as a ligand for stabilising G-quadruplex structures. It is shown here that BRACO-19 produces short- and long-term growth arrest in cancer cell lines, and is significantly less potent in a normal cell line. BRACO-19 reduces telomerase activity and long-term telomere length attrition is observed. It is also shown that BRACO-19 binds to telomeric single-stranded overhang DNA, consistent with quadruplex formation, and the single-stranded protein hPOT1 has been shown to be displaced from the overhang in vitro and in cellular experiments. It is concluded that the cellular activity of BRACO-19 can be ascribed both to the uncapping of 3' telomere ends and to telomere shortening that may preferentially affect cells with short telomeres.
机译:已经开发了三取代啶化合物BRACO-19作为稳定G-四链体结构的配体。在此显示,BRACO-19在癌细胞系中产生短期和长期的生长停滞,而在正常细胞系中的效力明显降低。 BRACO-19降低端粒酶活性,并观察到长期端粒长度磨损。还显示出BRACO-19结合端粒单链突出端DNA,与四链体形成一致,并且在体外和细胞实验中,单链蛋白hPOT1已显示出突出端。结论是,BRACO-19的细胞活性既可以归因于3'端粒末端的解封,也可以归因于端粒缩短,这可能会优先影响具有短端粒的细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号